FDA clears Median Technologies’ lung nodule evaluation software
FDA approval for eyonis LCS was supported by data from Median’s RELIVE (NCT06751576) pivotal trial, which met its primary endpoint,...
Technologies
Medical Care Technologies (OTC Pink:MDCE) Secures Access to One of the World’s Largest Public Skin Cancer Image Databases to Accelerate AI Development
MESA, Ariz., October 1, 2025 (Newswire.com) - Medical Care Technologies Inc. (OTC PINK:MDCE), an emerging developer of advanced healthcare AI...
bioAffinity Technologies Soars on Breakthrough Lung Cancer Diagnostic Data
bioAffinity Technologies, Inc. (NASDAQ: BIAF) has emerged as a standout performer in the financial markets today, September 26, 2025, with...
bioAffinity Technologies Soars on Breakthrough Lung Cancer Diagnostic Data
bioAffinity Technologies, Inc. (NASDAQ: BIAF) has emerged as a standout performer in the financial markets today, September 26, 2025, with...
